证监会剑指财务造假，发行人+中介机构被同步追责

Core Viewpoint - The article discusses the administrative penalties and market bans imposed by the China Securities Regulatory Commission (CSRC) on Lifan Shuke Co., Ltd. for falsifying financial data over three consecutive years, highlighting a shift towards stricter regulatory measures against financial fraud in the capital market [1][4]. Group 1: Company Specifics - Lifan Shuke has been found to have inflated its revenue and costs by a total of 638 million yuan (approximately 6.38 billion) from 2021 to 2023, with specific annual figures of 280 million yuan (2.80 billion) in 2021, 312 million yuan (3.12 billion) in 2022, and 46 million yuan (0.46 billion) in 2023 [4]. - The CSRC plans to impose a fine of 10 million yuan (1 million) on Lifan Shuke and an aggregate fine of 30 million yuan (3 million) on 10 responsible individuals [1][4]. Group 2: Regulatory Actions - The CSRC has initiated a comprehensive approach to combat financial fraud, which includes administrative penalties, market bans, criminal referrals, delisting procedures, and accountability for intermediaries [2][9]. - The case against Lifan Shuke marks a significant instance where both the company and the involved accounting firm, Zhongxing Caiguanghua, are being held accountable, reflecting a dual focus on punishing the primary offenders and their accomplices [5][9]. Group 3: Market Implications - Lifan Shuke is potentially the 14th company this year facing mandatory delisting due to financial fraud, indicating a record high for such cases in a single year [8]. - The regulatory environment has shifted towards a "zero tolerance" stance on financial fraud, with enhanced collaboration between the CSRC and the Supreme People's Procuratorate to ensure comprehensive accountability [8][9].